display:none
Skip to main content

DiMe Publications

Underuse of Oral Anticoagulants in Privately Insured Patients with Atrial Fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to ImProve treatment with Oral AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AFib)


Several members of DiMe’s leadership participated in a study, published in the American Heart Journal, concludes that there is an unmet need for evidence-based interventions that could lead to greater use of OACs in patients with AF at risk for stroke.

July 2020 in American Heart Journal

Join our next project

Help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients

Join the Integrated Evidence Plans project

Join us
Not today